20 questions: Round-up video
As it's our 20th year anniversary, we invited our employees to play our version of 20 questions throughout the year - this month we have created a final round-up video showcasing some of the best answers!
Patient centricity: Reality or rhetoric?
Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?
The term has certainly begun to filter through to the pharmaceutical market research industry. It was a hot topic at EphMRA conference in 2017, with a number of presentations from agencies, including some innovative new research offerings.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the campaign.
Emotional Recognition using Facial Analysis
Do you have a poker face or does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions, which is valuable to us as market researchers as we are interested in the emotional responses driving people’s attitudes and behaviours. We recently partnered with a tech company called Affectiva which has analysed over 5 million faces and 24,000 adverts to understand how people respond to digital stimulus such as advertising, websites and apps. Our client wanted to understand physicians’ response to communications materials designed for a disease awareness campaign, so their technology was ideal for the project’s objective.
Medical Marijuana: A Challenge to Traditional Pain Relief?
Published in Pharmaceutical Executive November 2017
Medical use of marijuana for a broad range of conditions is expanding rapidly in the US, as legalization gathers pace and investors flock to a booming market. A January 2017 report for the National Academies of Sciences, Engineering and Medicine (NASEM) found substantial or conclusive evidence of marijuana’s therapeutic benefit in chronic pain, multiple sclerosis and chemotherapy-induced nausea and vomiting. Other, more tentative US state-approved indications include diabetes, glaucoma, epilepsy, migraine, post-traumatic stress disorder, hepatitis C, Crohn’s disease, Parkinson’s disease and Tourette syndrome.